R&D Investments, Intangible Capital and Profitability in the Pharmaceutical Industry

Value Health. 2014 Nov;17(7):A419. doi: 10.1016/j.jval.2014.08.1025. Epub 2014 Oct 26.

Authors

I Goncharov¹, J C Mahlich², B Yurtoglu¹

Affiliations

¹ WHU-Otto Beisheim School of Management, Vallendar, Germany.
² Janssen-Pharmaceutical companies of Johnson & Johnson, Neuss, Germany.

PMID: 27201060
DOI: 10.1016/j.jval.2014.08.1025

No abstract available